Cell and gene therapy (CGT) manufacturing is rapidly transitioning from scientific curiosity to clinical reality. But the manufacturing complexity of CGTs far outpaces traditional biologics production, presenting a multifaceted challenge that is part scientific, part technological. “The manufacturing process for cell therapies and gene therapies is infinitely more complex than it is for let’s say,…